1 Patients being treated for schizophrenia now have a new administration site option for Abilify Maintena. 2  Approval was based on data demonstrating pharmacokinetics, tolerability and safety of Abilify Maintena when injected in the deltoid muscle of the arm being comparable to gluteal administration.